Eli Lilly and Novo Stock Sold Off. Don’t Blame Their Diet Drugs.

Stock in Eli Lilly and Novo Nordisk outperformed last year, largely because of remarkable demand for new drugs that drive weight loss in patients afflicted with diabetes and obesity. Both stocks were ...

Darren Aronofsky On ‘The Whale’ And Brendan Fraser’s Hollywood Second Coming

Brendan Fraser as Charlie in ‘The Whale.’ A24 The Whale came out of this year’s festival as a clear awards season favorite with critics and cinephiles. At the heart of that was Brend...

Low-Protein Diet From Processed Foods Drives Overeating And Is Fueling Obesity Crisis, Study Finds

Topline The low protein content of highly processed foods like soda, chips and fast food could be key to understanding why they are fueling rising rates of obesity in the Western world, according to r...

Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study

Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report is...

Buy Eli Lilly Stock. Its Obesity Drug Mounjaro Will Be a Hit, Analyst Says.

Text size Eli Lily said in August that initial demand for Mounjaro was strong. Daniel Acker/Bloomberg Eli Lilly’s novel treatment for diabetes and obesity could become one of history’s bestselling dru...

All Indulgent Foods Are Not Created Equal

New Georgetown University report challenges “junk food” tactics to reverse obesity Indulgent products are not created equal getty Stratospheric obesity rates in the United States are driving policies ...

To Tackle Obesity, Unleash The Food Industry

Industry can’t be relegated to the kid’s table at upcoming White House Conference The food industry needs a bigger role at the White House Conference on Hunger, Nutrition, and Health getty The White H...

Bill Maher Claims ‘Fat Celebration’ Is Happening In U.S., Oversimplifies Obesity Epidemic

On his HBO show “Real Time with Bill Maher,” Maher, who is not a scientist, claimed that that … [+] America has “gone from fat acceptance to fat celebration.” (Photo by Arturo Holmes...

NVO Stock: Obesity Sales Nearly Double, But That Wasn’t Enough For Investors

Danish drugmaker Novo Nordisk (NVO) missed second-quarter expectations Wednesday but raised its full-year outlook. NVO stock tumbled. X Sales climbed 25% to 41.27 million Danish Kroner — or about $5.6...